feed,title,long_url,short_url
MarketWatch,Bluebird Bio shares slide 34% after company suspends trials of sickle cell disease treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/hAXqS3zeeEc/story.aspx,https://on.mktw.net/3jVAk64
